Document |
Document Title |
WO/2006/080993A1 |
This invention relates to novel cationic crown-ether containing metal complexes, methods of preparing the cationic crown-ether containing metal complexes, and radiopharmaceutical compositions comprising the cationic crown-ether containin...
|
WO/2006/054466A1 |
A radioactive technetium complex that realizes enhancing of in a single photon discharge type tomogram, cardiac contrast and initial circulation extraction ratio; and a radioactive imaging diagnostic agent comprising the complex. The com...
|
WO/2006/043110A1 |
Complex salts, based on ionic liquids, which exhibit at least one light emitting property selected from (a) fluorescence, (b) phosphorescence, and (c) electroluminescence when in the solid state; and which have a melting point below 250°C.
|
WO/2006/041056A1 |
Disclosed is a metal-containing coordination compound represented by the formula (1) below and having characteristics equivalent to or better than those of metal complexes which can be polymerized or dissolved in a solvent. Also disclose...
|
WO/2006/037988A2 |
Novel radioactive technetium and rhenium complexes comprising tripodal ligands are provided by the present invention. In particular, Tc(I) complexes are provided by the present invention. Novel ligands suitable for the formation of the t...
|
WO/2006/032780A1 |
The invention concerns compounds of formula (I) and their use as catalyst.
|
WO/2006/026855A1 |
The invention provides a method for manufacturing or preparing neutral, low molecular weight 99mTc-labeled and 186Re-labeled carbohydrate complexes with an improved radiochemical yield from a simple functionalized sugar, such as glucosam...
|
WO/2006/024493A1 |
The invention relates to a novel method for producing organorhenium(VII) oxides
|
WO/2006/015414A1 |
The present invention provides an IR-absorbing naphthalocyanine dye of formula (I): wherein M is selected from Si(A1)(A2), Ge(A1)(A2), Ga(A1), Mg, Al(A1), TiO, Ti(A1)(A2), ZrO, Zr(A1)(A2), VO, V(A1)(A2), Mn, Mn(A1), Fe, Fe(A1), Co, Ni, C...
|
WO/2005/117907A2 |
Chiral ligands and metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The metal complexes according to the present invention are useful as catalysts in asymmetric reactions, such as, hydrogenation,...
|
WO/2005/116039A1 |
The present invention provides a novel class of molecular coordination compounds, and more particularly, square supramolecular metal coordination grids of the formula (I): [Ma2(L)2a]Xz (I), wherein M is a transition metal: a is 3, 4, 5 o...
|
WO/2005/108330A1 |
The aim of the invention is to provide radiolytically and metabolically stable metal complexes, which are suitable for conjugation with biomolecules and to provide a method for their production. This is achieved by metal complexes based ...
|
WO/2005/105303A1 |
The present invention relates to the use of certain manganese complexes having bispyridylpyrimidine or bispyridyltriazine ligands or mixtures of such ligands as catalysts for reactions with peroxy compounds for bleaching coloured stains ...
|
WO/2005/097808A2 |
Polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes, can be utilized in a number of applications, for example, as proton conductors in electrochemical devices. The presence of encapsulated metal atoms, preferabl...
|
WO/2005/097123A2 |
The present invention relates to Pyridyl-Substituted Porphyrin Compounds, compositions comprising an effective amount of a Pyridyl-Substituted Porphyrin Compound and methods for treating or preventing injury due to exposure to a reactive...
|
WO/2005/090371A1 |
A transition metal complex which is a bis-arylimine pyridine MXn complex, comprising a bis-arylimine pyridine ligand having the formula (I), wherein R1-R5, R7-R9, R12 and R14 are each, independently, hydrogen, optionally substituted hydr...
|
WO/2005/087697A1 |
[PROBLEMS] To provide a metal complex capable of being suitably used for manufacturing a metal-containing thin film by the CVD method and a method for manufacturing a metal-containing thin film. [MEANS FOR SOLVING PROBLEMS] A metal compl...
|
WO/2005/082894A1 |
The present invention relates to cell targeting conjugates and in particular, but not exclusively, to methods of their use in selectively eliminating and in selectively imaging target cells. The invention also relates to processes for pr...
|
WO/2005/079865A1 |
One aspect of the invention relates to complexes of a radionuclide with various heteroaryl ligands, e.g., imidazolyl and pyridyl ligands, and their use in radiopharmaceuticals for a variety of clinical diagnostic and therapeutic applicat...
|
WO/2005/079866A1 |
One aspect of the invention relates to complexes of technetium (Tc) and rhenium (Re) with various heteroaromatic ligands, e.g., quinolinyl and isoquinolinyl ligands, and their use in fluoresence and radioimaging for a variety of clinical...
|
WO/2005/077962A2 |
Compositions containing crowned dithiocarbamate metal complexes and methods of using these compositions; neutral and cationic radioactive metal-nitrido complexes of crowned dithiocarbamates (DTCs) and methods of using these complexes as ...
|
WO/2005/067388A2 |
The present invention relates to compounds that selectively bind to cells undergoing perturbations and alterations of their normal plasma membrane organization, such as cells undergoing apoptosis or activated platelets. The invention fur...
|
WO/2005/068074A2 |
The invention accordingly relates to the use as catalysts of at least one metal complex of formula (1) [LnMemXp]2Yq (1), wherein L is a ligand of formula (2) wherein Q1 is N or CR 10, Q2 is N or CR11, and wherein the remaining substituen...
|
WO2005033119A9 |
The application discloses the use of supramolecular compounds as antitumour, antimicrobial (such as antibacterial and antiprotozoal) and antiviral agents. Such compounds comprise ligands as defined in the application coordinated to at le...
|
WO/2005/044149A1 |
The present invention relates to hyaluronic acid polymers modified with non-proteinaceous catalysts for the dismutation of superoxide, and processes for making such materials. The invention further provides pharmaceutical compositions co...
|
WO/2005/026179A1 |
The invention provides ionic liquids having a secondary hydroxyl group, and an atom-efficient method for the preparation of these ionic liquids, by epoxidation of a protonated nitrogen- containing organic base (which can optionally be pr...
|
WO/2005/009963A1 |
Chelants and macrocyclic metal complexes thereof, methods of preparing the chelants and macrocyclic metal complexes, and radiopharmaceutical compositions comprising the macrocyclic metal complexes are disclosed. Methods of using the macr...
|
WO/2005/003126A1 |
Diarylethene-containing ligands and their coordination compounds are described. The ligands display photochromism with UV excitation, while the coordination compounds display photochromism with both excitation in the UV region and excita...
|
WO/2004/106390A2 |
This invention relates to a transition metal catalyst compound represented by the formula: LMX2 or (LMX2)2 wherein each M is independently a Group 7 to 11 metal, preferably a Group 7, 8, 9 or 10 metal; each L is, independently, a trident...
|
WO/2004/106939A2 |
The present invention relates to a method for radioactive labeling of a protein or peptide, by providing a protein or peptide having at least one glutamine or lysine residue; adding a metal chelating agent having at least one lysine or g...
|
WO/2004/096120A2 |
This invention provides new small-molecules capable of selective binding to membranes comprising and exposing phosphatidylserine on their surface and / or membranes which have increased amounts of phosphatidylethanolamine in their outer ...
|
WO/2004/092184A1 |
The aim of the invention is to propose substances, which after introduction into the body are mechanically stable vis-à-vis the chelate and are absorbed by the myocardium, and a method for producing said substances. Technetium-labelled ...
|
WO/2004/085497A2 |
This invention relates to transition metal catalyst compounds represented by the formula: LMX2 wherein M is a Group 7 to 11 metal, L is a tridentate or tetradentate neutrally charged ligand that is bonded to M by three or four nitrogen a...
|
WO/2004/076469A1 |
A method for the synthesis of methyltrioxorhenium is described, wherein 0.5-1.5 moles of dirhenium heptaoxide are reacted with 1-3 moles of tetramethyl tin in the presence of 1-3 moles of chlorotrimethyl silane. The synthesis is carried ...
|
WO/2004/064536A1 |
A process for preparation of stable, liquid solutions of complexes of trace elements and amino acid complexes of L-lysine, glycine, leucine, and serine. The resulting complexes are used to supplement domestic animals nutritionally. Since...
|
WO/2004/052357A1 |
The present invention is in the field of diagnostic imaging. In one aspect, the invention relates to novel imaging agents comprising synthetic macrophage scavenger receptor A antagonists, said imaging agents being useful in the diagnosti...
|
WO/2004/050031A2 |
Dimetalhydroxy malate compositions as well as methods of administering and making such bioavailable compositions are provided. The metal used can be any nutritionally relevant divalent metal such as calcium, magnesium, zinc, copper, mang...
|
WO/2004/043380A2 |
The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors. In another embodiment, the invention relates the metho...
|
WO/2004/044227A2 |
The invention provides, in a general sense, a new labeling strategy employing compounds that are are N2S2 chelates conjugated to a targeting ligand, wherein the targeting ligand is a disease cell cycle targeting compound, a tumor angioge...
|
WO/2004/041311A1 |
The present invention provides radioactive metal heterocomplexes of formula (I): [(Me=N-R) L1L2] +Z- (I), wherein Me, R, L1 L2 and Z- have the meanings indicated in the description. The complexes include a trivalent radioactive metal-imi...
|
WO/2004/032975A2 |
This invention relates to a method of imaging amyloid deposits and to labeled compounds, and methods of making labeled compounds useful in imaging amyloid deposits. This invention also relates to compounds, and methods of making compound...
|
WO/2004/026454A2 |
One aspect of the present invention relates to methods of preparing enedialkylidyne complexes, enediynes, and alkyne metathesis catalysts, as well as methods of catalyzing alkyne metathesis reactions. The present invention also relates t...
|
WO/2004/022105A2 |
The present invention relates to a process for generating a water soluble metal complexed agent, comprising contacting a solid phase bound organic conjugate represented by the formula I with [M(H2O)3(CO)3]n+, under suitable conditions to...
|
WO/2004/020549A1 |
Organic EL devices excellent in lifetime, luminous efficiency, color conversion efficiency, and so on, which each contain at least one organometallic complex selected from among (1) organometallic complexes which each comprise a rhenium ...
|
WO/2004/014927A1 |
The invention provides mitochondrially targeted antioxidant compounds comprising a lipophilic cation moiety covalently coupled to a glutathione peroxidase mimetic. These compounds can be used to treat patients who would benefit from the ...
|
WO/2004/007657A1 |
Use of metal complex compounds of formula (1) [LnMemXp]zYq wherein Me is manganese, titanium, iron, cobalt, nickel or copper, X is a coordinating or bridging radical, n and m are each independently of the other an integer having a value ...
|
WO/2004/004635A2 |
The invention, in one aspect, relates to radiolabeled compounds. The invention also relates to radiolabeled liposomes and methods of making and using thereof. The invention also relates to kits for preparing radiolabeled liposomes.
|
WO/2004/000986A1 |
Transition metal complexes are used as bleaching catalysts for peroxy compounds. Transition metal complexes to be used according to the invention contain a ligand of the general formula (I) wherein B is a bridge member, such as o-phenyle...
|
WO/2003/106610A1 |
Transition metal complexes are used as a bleaching catalyst for peroxy compounds. Transition metal complexes to be used according to the invention contain a polydentate ligand of the general formula (I), wherein B preferably denotes a he...
|
WO/2003/101948A2 |
The present invention provides novel compounds that bind selectively to cells undergoing perturbations and alterations of the normal organization of their plasma membrane, while binding to a lesser degree to cells having membranes of nor...
|